Mild Breakthrough Infection in a Healthcare Professional Working in the Isolation Area of a Hospital Designated for Treating COVID-19 Patients - Shaanxi Province, China, March, 2021
Overview
Affiliations
What Is Already Known About This Topic?: Healthcare workers are at high risk of acquiring COVID-19 from occupational exposure to COVID-19 virus during their daily medical service work. Excellent infection prevention and control measures and adequate personal protective equipment (PPE) are essential to reduce the risk of hospital-acquired COVID-19.
What Is Added By This Report?: On March 17, 2021, a female healthcare professional who already received both doses of the COVID-19 vaccination and was working in the isolation area of a designated COVID-19 hospital was diagnosed with COVID-19 in Xi'an city. Her exposure likely occurred five days before illness onset when she obtained nasopharyngeal and oropharyngeal swabs from the two imported cases that were identified as belonging to the B.1.1.7 lineage, the variant first detected in the United Kingdom.
What Are The Implications For Public Health Practices?: Since the healthcare worker had been fully vaccinated and had mild symptomatology, it is considered a mild breakthrough infection. All vaccines are associated with breakthrough infections. In addition to rigorous adherence to infection prevention and control measures, use of adequate PPE, and using good clinical practices, the potential role of chronic upper respiratory infection in acquiring COVID-19 during medical procedures deserves further consideration.
Anshory M, Wahono C, Pratama M, Rahman P, Nugraha A, Sekarani A J Res Health Sci. 2022; 22(2):e00551.
PMID: 36511263 PMC: 9818040. DOI: 10.34172/jrhs.2022.86.
Risk of SARS-CoV-2 reinfection: a systematic review and meta-analysis.
Deng L, Li P, Zhang X, Jiang Q, Turner D, Zhou C Sci Rep. 2022; 12(1):20763.
PMID: 36456577 PMC: 9714387. DOI: 10.1038/s41598-022-24220-7.
Comprehensive narrative review of real-world COVID-19 vaccines: viewpoints and opportunities.
Liu S, Kang M, Zhao N, Zhuang Y, Li S, Song T Med Rev (2021). 2022; 2(2):169-196.
PMID: 35862507 PMC: 9274757. DOI: 10.1515/mr-2021-0021.
Kanakan A, Mehta P, Devi P, Saifi S, Swaminathan A, Maurya R Front Microbiol. 2022; 13:763169.
PMID: 35308382 PMC: 8927057. DOI: 10.3389/fmicb.2022.763169.
Higher Vaccination Rate Predicts Reduction in SARS-CoV-2 Transmission across the United States.
Au J medRxiv. 2021; .
PMID: 34816265 PMC: 8609904. DOI: 10.1101/2021.11.14.21266325.